Burkhard Jansen is Chief Medical Officer of DermTech, Inc.. Currently has a direct ownership of 84,991 shares of DMTK, which is worth approximately $3,399. The most recent transaction as insider was on Mar 29, 2021, when has been sold 4,897 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85K
0% 3M change
0% 12M change
Total Value Held $3,399

Burkhard Jansen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2021
BUY
Grant, award, or other acquisition
-
4,897 Added 5.45%
84,991 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$34,700 $6.94 p/Share
5,000 Added 5.95%
79,037 Common Stock
Dec 14 2020
SELL
Open market or private sale
$62,050 $12.41 p/Share
5,000 Reduced 5.95%
79,037 Common Stock
Dec 11 2020
SELL
Open market or private sale
$61,000 $12.2 p/Share
5,000 Reduced 6.33%
74,037 Common Stock
BJ

Burkhard Jansen

Chief Medical Officer
La Jolla, CA

Track Institutional and Insider Activities on DMTK

Follow DermTech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMTK shares.

Notify only if

Insider Trading

Get notified when an Derm Tech, Inc. insider buys or sells DMTK shares.

Notify only if

News

Receive news related to DermTech, Inc.

Track Activities on DMTK